Skip to content

E77.0

Billable

Defects in post-translational modification of lysosomal enzymes

HCC Category Mapping

V24HCC 23Other Significant Endocrine and Metabolic Disorders
0.230
ESRDHCC 23Other Significant Endocrine and Metabolic Disorders
0.000
RxHCCHCC 41Lysosomal Storage Disorders
0.000

What This Code Means

A rare genetic disorder affecting how the body modifies and processes lysosomal enzymes, which are proteins that break down waste materials in cells.

Coding Tips

  • This code requires documentation of the specific enzyme defect when available
  • Often associated with lysosomal storage diseases; review clinical findings for more specific diagnosis

Clinical Significance

Defects in post-translational modification of lysosomal enzymes includes mucolipidosis II (I-cell disease) and mucolipidosis III (pseudo-Hurler polydystrophy), where lysosomal enzymes are not properly tagged for delivery to lysosomes. These are severe conditions with clinical features overlapping MPS but with distinct pathophysiology, requiring differentiation for appropriate genetic counseling and management.

Documentation Requirements

  • Specific disorder documented: mucolipidosis II (I-cell disease) or mucolipidosis III (pseudo-Hurler polydystrophy)
  • Confirmatory testing: elevated serum lysosomal enzyme levels, decreased intracellular enzyme activity, or GNPTAB/GNPTG gene mutations
  • Clinical manifestations: skeletal abnormalities, coarse features, developmental delay, cardiac involvement
  • Differentiation from MPS documented (different enzyme trafficking defect mechanism)
  • Treatment plan and current disease status

Commonly Confused Codes

Code Hierarchy

Open E77.0 in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.